Terms: = Lymphoma AND TLX3, O43711, 30012, ENSG00000164438, HOX11L2, RNX AND Treatment
19 results:
1. [Characteristics and prognostic effects of NOTCH1/FBXW7 gene mutations in T-cell acute lymphoblastic leukemia patients].
Wu CY; Li YL; Dong XY; Yang SW; Shang BJ; Zhang L; Cheng W; Zhang L; Zhu ZM
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(25):1910-1917. PubMed ID: 35768390
[No Abstract] [Full Text] [Related]
2. Effect of Mimic Hypoxia on the Proliferation and Expression of miR-27a, miR-9, miR-370 and their Target Genes in MOLT-4 and KG1a Cell Lines.
Emaogolizadeh Gurd Tapeh B; Mohammadi A; Alivand MR; Solali S
Asian Pac J Cancer Prev; 2021 Jun; 22(6):1975-1984. PubMed ID: 34181359
[TBL] [Abstract] [Full Text] [Related]
3. Epigenetic analysis of patients with T-ALL identifies poor outcomes and a hypomethylating agent-responsive subgroup.
Touzart A; Mayakonda A; Smith C; Hey J; Toth R; Cieslak A; Andrieu GP; Tran Quang C; Latiri M; Ghysdael J; Spicuglia S; Dombret H; Ifrah N; Macintyre E; Lutsik P; Boissel N; Plass C; Asnafi V
Sci Transl Med; 2021 May; 13(595):. PubMed ID: 34039737
[TBL] [Abstract] [Full Text] [Related]
4. Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia.
Vanden Bempt M; Demeyer S; Broux M; De Bie J; Bornschein S; Mentens N; Vandepoel R; Geerdens E; Radaelli E; Bornhauser BC; Kulozik AE; Meijerink JP; Bourquin JP; de Bock CE; Cools J
Cancer Cell; 2018 Aug; 34(2):271-285.e7. PubMed ID: 30107177
[TBL] [Abstract] [Full Text] [Related]
5. Immunophenotyping with CD135 and CD117 predicts the FLT3, IL-7R and tlx3 gene mutations in childhood T-cell acute leukemia.
Noronha EP; Andrade FG; Zampier C; de Andrade CF; Terra-Granado E; Pombo-de-Oliveira MS;
Blood Cells Mol Dis; 2016 Mar; 57():74-80. PubMed ID: 26852660
[TBL] [Abstract] [Full Text] [Related]
6. Newly diagnosed acute lymphoblastic leukemia in China (I): abnormal genetic patterns in 1346 childhood and adult cases and their comparison with the reports from Western countries.
Chen B; Wang YY; Shen Y; Zhang WN; He HY; Zhu YM; Chen HM; Gu CH; Fan X; Chen JM; Cao Q; Yang G; Jiang CL; Weng XQ; Zhang XX; Xiong SM; Shen ZX; Jiang H; Gu LJ; Chen Z; Mi JQ; Chen SJ
Leukemia; 2012 Jul; 26(7):1608-16. PubMed ID: 22382891
[TBL] [Abstract] [Full Text] [Related]
7. Genetic rearrangements in relation to immunophenotype and outcome in T-cell acute lymphoblastic leukaemia.
Meijerink JP
Best Pract Res Clin Haematol; 2010 Sep; 23(3):307-18. PubMed ID: 21112032
[TBL] [Abstract] [Full Text] [Related]
8. NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols.
Zuurbier L; Homminga I; Calvert V; te Winkel ML; Buijs-Gladdines JG; Kooi C; Smits WK; Sonneveld E; Veerman AJ; Kamps WA; Horstmann M; Petricoin EF; Pieters R; Meijerink JP
Leukemia; 2010 Dec; 24(12):2014-22. PubMed ID: 20861909
[TBL] [Abstract] [Full Text] [Related]
9. ABL1 rearrangements in T-cell acute lymphoblastic leukemia.
Hagemeijer A; Graux C
Genes Chromosomes Cancer; 2010 Apr; 49(4):299-308. PubMed ID: 20073070
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic relevance of tlx3 (hox11l2) expression in childhood T-cell acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing early and late re-intensification elements.
Attarbaschi A; Pisecker M; Inthal A; Mann G; Janousek D; Dworzak M; Pötschger U; Ullmann R; Schrappe M; Gadner H; Haas OA; Panzer-Grümayer R; Strehl S;
Br J Haematol; 2010 Jan; 148(2):293-300. PubMed ID: 19821827
[TBL] [Abstract] [Full Text] [Related]
11. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of tlx3/hox11l2 gene expression on outcome.
Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
[TBL] [Abstract] [Full Text] [Related]
12. Thymic adult T-cell acute lymphoblastic leukemia stratified in standard- and high-risk group by aberrant hox11l2 expression: experience of the German multicenter ALL study group.
Baak U; Gökbuget N; Orawa H; Schwartz S; Hoelzer D; Thiel E; Burmeister T;
Leukemia; 2008 Jun; 22(6):1154-60. PubMed ID: 18368072
[TBL] [Abstract] [Full Text] [Related]
13. Activation of tlx3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1.
Nagel S; Scherr M; Kel A; Hornischer K; Crawford GE; Kaufmann M; Meyer C; Drexler HG; MacLeod RA
Cancer Res; 2007 Feb; 67(4):1461-71. PubMed ID: 17308084
[TBL] [Abstract] [Full Text] [Related]
14. High expression of the ETS transcription factor ERG predicts adverse outcome in acute T-lymphoblastic leukemia in adults.
Baldus CD; Burmeister T; Martus P; Schwartz S; Gökbuget N; Bloomfield CD; Hoelzer D; Thiel E; Hofmann WK
J Clin Oncol; 2006 Oct; 24(29):4714-20. PubMed ID: 16954520
[TBL] [Abstract] [Full Text] [Related]
15. Impact of TCR status and genotype on outcome in adult T-cell acute lymphoblastic leukemia: a LALA-94 study.
Asnafi V; Buzyn A; Thomas X; Huguet F; Vey N; Boiron JM; Reman O; Cayuela JM; Lheritier V; Vernant JP; Fiere D; Macintyre E; Dombret H
Blood; 2005 Apr; 105(8):3072-8. PubMed ID: 15637138
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia.
Ferrando AA; Neuberg DS; Dodge RK; Paietta E; Larson RA; Wiernik PH; Rowe JM; Caligiuri MA; Bloomfield CD; Look AT
Lancet; 2004 Feb; 363(9408):535-6. PubMed ID: 14975618
[TBL] [Abstract] [Full Text] [Related]
17. Gene expression profiling in T-cell acute lymphoblastic leukemia.
Ferrando AA; Look AT
Semin Hematol; 2003 Oct; 40(4):274-80. PubMed ID: 14582078
[TBL] [Abstract] [Full Text] [Related]
18. Clinical significance of hox11l2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951.
Cavé H; Suciu S; Preudhomme C; Poppe B; Robert A; Uyttebroeck A; Malet M; Boutard P; Benoit Y; Mauvieux L; Lutz P; Méchinaud F; Grardel N; Mazingue F; Dupont M; Margueritte G; Pages MP; Bertrand Y; Plouvier E; Brunie G; Bastard C; Plantaz D; Vande Velde I; Hagemeijer A; Speleman F; Lessard M; Otten J; Vilmer E; Dastugue N;
Blood; 2004 Jan; 103(2):442-50. PubMed ID: 14504110
[TBL] [Abstract] [Full Text] [Related]
19. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia.
Ferrando AA; Neuberg DS; Staunton J; Loh ML; Huard C; Raimondi SC; Behm FG; Pui CH; Downing JR; Gilliland DG; Lander ES; Golub TR; Look AT
Cancer Cell; 2002 Feb; 1(1):75-87. PubMed ID: 12086890
[TBL] [Abstract] [Full Text] [Related]
